Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate superior efficacy of sustained release quetiapine
compared to placebo in patients with schizophrenia after receiving treatment for up to 6
weeks.